CANDACE KIRKPATRICK: Open Payments
NPI 1437680394 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 24 payments from 8 companies in 2025. Trend: 2023 $417 · 2024 $788 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $254 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Lundbeck LLC | 2 | $34 |
| Amgen Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $17 |
| Philips North America LLC | 1 | $14 |
Products named: REXULTI, GEMTESA, BREZTRI, Dexcom G6 Transmitter, Ozempic, REPATHA, OTEZLA, Vest Therapy Und.
Industry payments across MO — which companies pay providers there.
